|A few of the many poster presenters
at the 2011 COSHP Research Day
The 7th annual College of Sciences and Health Professions Research Day was held Friday, April 15th, 2011 at Cleveland State University's Physical Education building and Fenn Tower.
Research Day is an opportunity for COSHP students and faculty to present and share posters of their current research, teaching and service accomplishments. They represent the strong commitment of our faculty and students to scholarship. Each year the posters demonstrate a wide range of exploration, from basic science to direct health care, from mathematical modeling to research on educational strategies. The work reflects not only the scholarly interests of individuals, but the close relationship between scholarly and educational endeavors.
Research Day features a keynote presentation by a scientist, researcher, or academician in one of the College of Sciences and Health Professions disciplines. Also, as recognition of the research and scholarly accomplishments of our faculty, Dr. Valentin Gogonea, as nominated by his colleagues, was presented with the 2011 Outstanding Research Award. This year's keynote speaker was Dr. Sailen Barik.
Sailen Barik, Ph.D. was recently recruited to serve as the first Director of the CSU Center for Gene Regulation in Health and Disease (GRHD). He is also a Professor in the Department of Biological, Geological and Environmental Sciences. Dr. Barik received his Ph.D. in Biochemistry from Bose Institute and postdoctoral training in Microbiology at the University of Connecticut Health Center. He became a faculty member at the Cleveland Clinic in 1989, and then moved to the University of South Alabama, College of Medicine in 1994, where he became a full Professor in 2003.
Dr. Barik's research spans cardio-pulmonary infection and inflammation, with emphasis on host-pathogen interactions and RNA interference (RNAi). His group pioneered the intranasal delivery of RNAi, featured in PBS-NOVA and later, advanced to the first successful clinical trial of antiviral RNAi. Published in over 100 papers that were collectively cited more than 3300 times, his research resulted in two US and European Patents and has been continuously funded since 1994 by NIH, NSF, American Heart Association, American Cancer Society and Burroughs-Wellcome Foundation. His group, as part of a consortium, recently received a highly selective Michael J. Fox Foundation Therapeutic Development grant on Parkinson's Disease. He has served as a grant reviewer for many funding agencies, as a member of a variety of institutional and advisory committees, as reviewer and Editor of papers and books, and has delivered nearly 50 invited lectures. Dr. Barik has been an active teacher and mentor as well, and eight PhD students graduated under his directed guidance.
In his role as the Director of GRHD, Dr. Barik leads a group of CSU chemistry and cell and molecular biology faculty in advanced biomedical research. Their research focuses on improving understanding of biological processes and how the malfunction of these processes results in various diseases. This research has significant potential to improve our understanding of the mechanisms and specific molecules that control reproductive health and those that control the aging process as well as implications for the diagnosis and treatment of many of the most common diseases found around the world, including heart disease, neurological disease, infectious disease and cancer.